rs587780882
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000719.7(CACNA1C):c.375A>G(p.Pro125Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000145 in 1,514,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000719.7 synonymous
Scores
Clinical Significance
Conservation
Publications
- Timothy syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizuresInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- long QT syndromeInheritance: AD Classification: MODERATE Submitted by: ClinGen
- long QT syndrome 8Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
- Brugada syndrome 3Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- short QT syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.465A>G | p.Pro155Pro | synonymous_variant | Exon 3 of 50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.465A>G | p.Pro155Pro | synonymous_variant | Exon 3 of 48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.465A>G | p.Pro155Pro | synonymous_variant | Exon 3 of 47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.465A>G | p.Pro155Pro | synonymous_variant | Exon 3 of 47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.465A>G | p.Pro155Pro | synonymous_variant | Exon 3 of 47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.465A>G | p.Pro155Pro | synonymous_variant | Exon 3 of 47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.375A>G | p.Pro125Pro | synonymous_variant | Exon 3 of 46 | ENSP00000507309.1 | ||||
CACNA1C | ENST00000682152.1 | c.324A>G | p.Pro108Pro | synonymous_variant | Exon 2 of 6 | ENSP00000506759.1 | ||||
CACNA1C | ENST00000480911.6 | n.375A>G | non_coding_transcript_exon_variant | Exon 3 of 27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152200Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000601 AC: 15AN: 249396 AF XY: 0.0000887 show subpopulations
GnomAD4 exome AF: 0.0000117 AC: 16AN: 1362124Hom.: 0 Cov.: 24 AF XY: 0.0000146 AC XY: 10AN XY: 683734 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
Variant summary: CACNA1C c.375A>G alters a non-conserved nucleotide resulting in a synonymous change. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 6e-05 in 249396 control chromosomes, predominantly at a frequency of 0.00077 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 80 fold of the estimated maximal expected allele frequency for a pathogenic variant in CACNA1C causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. To our knowledge, no occurrence of c.375A>G in individuals affected with Arrhythmia and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and both laboratories classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Long QT syndrome Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at